GRIFOLS | GRF - Текущие активы





Текущие активы Изменить Дата
Alcon AG USD 6.62B 4M 2026-06
Almirall EUR 747.1M 33.12M 2026-06
Amadeus IT EUR 2.64B 5.6M 2026-09
Amarin USD 612.88M 10.12M 2026-09
argenx SE USD 8.07B 1.17B 2026-06
AstraZeneca USD 31.45B 3.48B 2026-09
Bayer EUR 39.6B 5.96B 2026-09
Cie Automotive EUR 1.8B 6.22M 2025-12
Demant DKK 10.2B 130M 2026-06
Ence Energia y Celulosa EUR 407M 10.3M 2026-09
Essilor EUR 11.24B 770M 2026-06
Ferrovial EUR 6.81B 500M 2026-06
Fresenius EUR 12.29B 678M 2026-09
Fresenius Medical Care EUR 7.84B 150.6M 2026-09
Genmab DKK 2.8B 228M 2026-06
GlaxoSmithKline GBP 17.9B 336M 2026-09
GRIFOLS EUR 5.35B 40M 2026-09
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Inditex EUR 15.7B 392M 2026-06
Lakefront Biotherapeutics EUR 2.31B 751.38M 2026-06
Merck EUR 13.77B 393M 2026-06
Novartis USD 28.75B 1.4B 2026-09
Philips EUR 10.51B 1.18B 2026-09
Roche Holding CHF 35.44B 3.29B 2026-06
Sanofi EUR 33.21B 1.68B 2026-09
Smith & Nephew USD 4.39B 240M 2026-06
UCB EUR 6.05B 733M 2025-12
Viscofan EUR 876.65M 14.22M 2026-09